News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Covis Pharmaceuticals Selects CIS Commercial Compliance and Government Programs Services


6/10/2013 9:40:47 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!



PHILADELPHIA, Pa., June 10, 2013 – Covis Pharmaceuticals, Inc. a specialty pharmaceutical distributor dedicated to improving patient lives by offering products that treat life-threatening conditions and chronic illnesses, selected Compliance Implementation Services (CIS) to develop and implement a corporate compliance program, and manage the ongoing compliance and requirements of Government Program (GP) participation.

Key to Covis’ business strategy was the commercial launch of branded products that had been acquired from a leading pharmaceutical manufacturer. As a relatively new specialty pharmaceutical distributor in the US, Covis understood the need to develop a corporate compliance program, as well as devise an operational strategy that ensured compliance and reporting accuracy in their Medicaid, Medicare, TRICARE, Federal Supply Schedule (FSS), and Public Health Service (PHS) programs.

“With all of the pricing and market access pressures that I must stay focused on, it was a relief to know that CIS was able to quickly step in and help manage some of the operational burdens that come with establishing a corporate compliance culture while ensuring that all requirements were met with one of our key customers - the US government,” said Bill Collins, Chief-Executive-Officer of Covis.

CIS developed a Corporate Compliance plan that outlined Covis’ commitment to compliance and ethics, as well as support for gaining entry into multiple federal and government programs by assistance with the submission process and development of key documentation that would provide necessary audit trails and assurance that revenue loss did not occur within the new government contracts.

“As manufacturers are facing increased agency scrutiny a clear understanding of the changes on the federal and state level is required. Covis wanted a partner who understood how Healthcare Reform would impact their business and could evaluate their product portfolio and contracting strategies to address changes in the various federal programs,” said Chris Cobourn, Senior Vice President, Commercial Compliance at CIS. “CIS’ experts successfully built and integrated a corporate compliance program, set up a GP operation, and provided ongoing GP support.”

About Covis Pharmaceuticals, Inc.

Covis Pharmaceuticals is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. It is our mission to provide our customers with a continuous supply of safe and efficacious therapeutic solutions. The Website is: www.covispharma.com.

About Compliance Implementation Services (CIS)

Compliance Implementation Services (CIS) is a consulting firm focused on helping life sciences clients proactively manage complex compliance requirements. We offer a broad portfolio of services and solutions that expand deep into the clinical, manufacturing and commercial disciplines and that align with our clients’ strategic priorities and business operations. CIS continually provides leadership, global regulatory knowledge, industry experience and a problem-solving culture that responds to today’s compliance and commercial challenges. For more information, visit www.cis-partners.com

Company Contact Information

Compliance Implementation Services

Christine Pahl

3809 West Chester Pike, Newtown Square, PA

Suite 100

19073

919-714-6456

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES